Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rudd

Showing results (281-290 of 289) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 289 results.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 10, 2019
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registryThompson G Robinson, Benjamin D Bray, Lizz Paley, et al.
Iscience|February 6, 2024
Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelSi Min Zhang, Cynthia B J Paulin, Huazhang Shu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2025
Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase FunctionMario Kehler, Kaixin Zhou, Aurino M Kemas, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Nature Chemical Biology|July 22, 2020
Development of a chemical probe against NUDT15Si Min Zhang, Matthieu Desroses, Anna Hagenkort, et al.
International Journal of Molecular Sciences|February 27, 2026
Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in <i>C9orf72</i> Amyotrophic Lateral Sclerosis via ADABenjamin Hall, Lydia Castelli, Adrian Higginbottom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2016
Validation and development of MTH1 inhibitors for treatment of cancerU Warpman Berglund, K Sanjiv, H Gad, et al.
Pageof 29

Showing results (281-290 of 289) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 289 results.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 10, 2019
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registryThompson G Robinson, Benjamin D Bray, Lizz Paley, et al.
Iscience|February 6, 2024
Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelSi Min Zhang, Cynthia B J Paulin, Huazhang Shu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2025
Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase FunctionMario Kehler, Kaixin Zhou, Aurino M Kemas, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Nature Chemical Biology|July 22, 2020
Development of a chemical probe against NUDT15Si Min Zhang, Matthieu Desroses, Anna Hagenkort, et al.
International Journal of Molecular Sciences|February 27, 2026
Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in <i>C9orf72</i> Amyotrophic Lateral Sclerosis via ADABenjamin Hall, Lydia Castelli, Adrian Higginbottom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2016
Validation and development of MTH1 inhibitors for treatment of cancerU Warpman Berglund, K Sanjiv, H Gad, et al.
Pageof 29